logo
Which Cryptocurrency Is More Likely to Be a Millionaire Maker? XRP vs. Cardano

Which Cryptocurrency Is More Likely to Be a Millionaire Maker? XRP vs. Cardano

Yahooa day ago

XRP and Cardano might both grow significantly in the coming years.
XRP's primary appeal is its strong association with institutional capital.
Cardano's dedicated and active developer base could prove to be a major asset.
10 stocks we like better than XRP ›
XRP (CRYPTO: XRP) and Cardano (CRYPTO: ADA) have both been pitched as potential fast tracks to building up a hoard of seven figures. While it's generally not appropriate for serious investors to make purchases in the hopes of making millions overnight, over a long enough timescale, with enough diligent investment and the right asset selected, it is indeed possible.
Between these two coins, both are well known, liquid, and still nowhere near their prior all‑time highs. That combination tempts bargain hunters. But price alone never mints millionaires, even in crypto; it's necessary to have a real set of fundamentals that'll drive a large influx of new capital even after a large amount has already shown up and stuck around.
Let's examine which of these two actually has a credible shot at compounding long enough to turn persistent dollar‑cost averaging (DCA) into life‑changing gains.
Let's start with some cold back-of-the-napkin arithmetic.
XRP changes hands at about $2.19 today. A $10,000 position would need roughly a 100x gain to reach $1 million, at which point the coin's market cap would be roughly $11 trillion. For Cardano, it'd require a future market cap of around $2.3 trillion. Those numbers are long shots for both, but which chain has the better odds?
Utility is a good starting proxy. On June 15, the XRP Ledger (XRPL) processed 5.1 million transactions in a single day, breaching its former records. That speaks directly to its core use case, which is to make cross-border transactions cheaper and faster than they would be using legacy technologies. High volume is a clear sign that its target user base, which is to say, institutional investors, are at least to some degree utilizing the chain for what it was intended to do.
In contrast, Cardano lately averages closer to 50,000 daily transactions. It isn't precisely clear who the chain's target users are meant to be, but regardless of who it is, they do not appear to be actually using the chain very much at all in the grand scheme of things. That means it is less likely to grow rapidly.
XRP also has an edge when it comes to competing in growth markets, like real‑world‑asset (RWA) tokenization. XRPL already hosts roughly $160 million in tokenized bonds, treasuries, and other off‑chain assets. Per some estimates, the tokenized asset market could grow from $0.6 trillion this year to reach $18.9 trillion by 2033.
If XRP keeps compounding its early share of that pie, a pathway to triple‑digit gains exists. But Cardano has no comparable wedge into the same megatrend right now -- and, quite concerningly, it isn't actually exposed to any other trending growth segments either.
Tech development is a major part of each coin's potential to make investors into millionaires. Once again, XRP takes the win.
Ripple, the business that issues XRP, has spent 2025 adding tools that its core customer base actually wants. Ripple's developer summit this month unveiled identity‑layer upgrades that bake know‑your‑customer (KYC) regulatory compliance into the protocol, which is an existential requirement for large asset managers.
Cardano, unfortunately, remains heavy on research papers and light on production traffic.
Hydra, its long‑promised layer‑2 (L2) scaling system, is still in bug‑fix mode after recent security checks. Meanwhile, daily active wallet addresses hover near 24,000 -- far from being a user base of inspiring size. The chain's entire fee haul is less than $8,000 per day. Those metrics would be respectable for a start-up network, but they are tepid for a 9‑year‑old project.
Developer activity is the lone area where Cardano shines, as in early 2025, it ranked among the top three chains in terms of updates pushed. Those high commit counts show some momentum, yet code is only valuable when users need what is being built, which is the main problem with the chain. Until Cardano's decentralized finance (DeFi) features become must‑have features for a defined audience, its robust research culture may not translate into price appreciation, and so far, it hasn't.
For investors, the takeaway is clear. XRP is already solving paying customers' problems and charging fees to do so. Cardano is still refining the pitch.
XRP is the coin that is more likely to make investors richer, but it probably won't deliver the eye-popping returns overnight that are necessary to make millionaires.
Still, if the goal is to choose the stronger long‑term compounding machine, XRP currently offers better odds. Its growing transaction flow, embedded regulatory compliance features, and head start in the swelling RWA market create tangible revenue streams that can support higher valuations.
Separately, Cardano remains an interesting technology play, and its staunch community plus academic rigor may yet pay off. For now, though, owning the coin is a wager that the team will eventually find a killer use case that drives non‑speculative demand. That might happen, but until it does, it is an investment thesis in search of evidence, not a smart place to put your capital.
Before you buy stock in XRP, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and XRP wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!*
Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 23, 2025
Alex Carchidi has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends XRP. The Motley Fool has a disclosure policy.
Which Cryptocurrency Is More Likely to Be a Millionaire Maker? XRP vs. Cardano was originally published by The Motley Fool

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sterilization Equipment Market to Reach $29.2 Billion by 2032, Growing at a CAGR of 8.2% from 2025, Says Meticulous Research®
Sterilization Equipment Market to Reach $29.2 Billion by 2032, Growing at a CAGR of 8.2% from 2025, Says Meticulous Research®

Yahoo

time38 minutes ago

  • Yahoo

Sterilization Equipment Market to Reach $29.2 Billion by 2032, Growing at a CAGR of 8.2% from 2025, Says Meticulous Research®

Market Growth Driven by Rising Hospital-Acquired Infections, Increasing Surgical Procedures, Enhanced Food Industry Sterilization Focus, and Growing Pharmaceutical & Biotechnology Demand REDDING, Calif., June 30, 2025 /PRNewswire/ -- According to a comprehensive market research report titled "Sterilization Equipment Market Size, Share, Forecast, & Trends Analysis by Offering (Equipment [Heat {Moist (Gravity, High-speed), Dry (Static Air, Forced Air)}, Low-temperature {ETO, Formaldehyde}, Radiation, Filtration] Services - Global Forecast to 2032", the Sterilization Equipment market is projected to reach $29.2 billion by 2032, up from an estimated $16.8 billion in 2025, growing at a robust CAGR of 8.2% during the forecast period. The growth of the sterilization equipment market is primarily driven by the increasing prevalence of hospital-acquired infections, a rise in surgical procedures, and an enhanced focus on sterilization within the food industry to mitigate food-borne illnesses. Additionally, there is growing demand for sterilization equipment from pharmaceutical and biotechnology sectors, alongside a trend toward outsourcing sterilization processes to specialized service providers in non-healthcare industries. The industry is experiencing revolutionary transformation through advanced technology integration, including AI and robotics adoption, ozone sterilization innovations, and development of carbon dioxide (CO2) sterilization alternatives to ethylene oxide. Leading companies are embracing digital sterilization technologies while expanding into emerging markets and developing innovative solutions for complex sterilization challenges across healthcare and non-healthcare sectors. For more comprehensive insights, download the FREE report sample: Revolutionary Market Transformation Through Advanced Sterilization Excellence The sterilization equipment market represents a paradigm shift in infection control and contamination prevention across multiple industries. As healthcare facilities increasingly prioritize patient safety while pharmaceutical and biotechnology companies seek specialized sterilization expertise, advanced sterilization equipment offers a revolutionary solution that addresses the growing demand for effective, efficient, and environmentally sustainable sterilization processes. Market leaders are investing heavily in next-generation sterilization technologies and automated systems, establishing capabilities that can deliver scalable, reliable sterilization solutions. This technological advancement is making sophisticated sterilization processes increasingly accessible while delivering superior microbial reduction and operational efficiency benefits. Dynamic Growth Across Key Market Segments Based on offering, the Equipment segment dominates the market in 2025, capturing approximately 55% of the total market share due to rising incidence of hospital-acquired infections, high adoption of sterilization equipment in medical devices and pharmaceutical industries, and increasing need to ensure safety of food & beverages. The Services segment is experiencing significant growth driven by outsourcing trends and specialized sterilization requirements. Based on end users, the Hospitals & Clinics segment leads the market with approximately 35.9% share, reflecting the high prevalence of HAIs, rising number of surgical procedures, growing demand for clean and quality healthcare facilities, and increasing burden of chronic diseases associated with an aging population. According to the World Health Organization (WHO), out of every 100 patients in acute care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will be affected by at least one healthcare-acquired infection during their hospital stay. The Medical Device Companies segment is also experiencing robust growth, driven by stringent regulatory requirements and the need for specialized sterilization processes for complex medical devices and instruments. Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) - Strategic Market Opportunities and Innovation Drivers The market presents extraordinary growth opportunities through advanced technology integration, emerging market expansion, and development of environmentally sustainable sterilization solutions. Companies are discovering new revenue streams through CO2 sterilization capabilities, ozone sterilization technologies, and comprehensive infection control ecosystems. Key market drivers include: Rising Hospital-Acquired Infections: Increasing prevalence of HAIs compelling healthcare facilities to invest in advanced sterilization equipment and protocols to ensure patient safety and regulatory compliance Advanced Sterilization Technologies: Integration of AI, robotics, ozone generation, and supercritical CO2 systems enhancing efficiency, precision, and environmental sustainability in sterilization processes Pharmaceutical & Biotechnology Growth: Expanding demand from pharmaceutical and biotechnology industries for specialized sterilization solutions supporting complex biologics manufacturing and sterile processing environments Food Industry Safety Focus: Growing emphasis on food safety and prevention of food-borne illnesses driving adoption of advanced sterilization equipment in food & beverage processing facilities Regional Market Leadership and Emerging Growth North America commands the largest market share in 2025 with approximately 46% of the global market, driven by growing hospital & outpatient visits, rising number of surgical procedures, growing incidence of HAIs, increasing healthcare expenditure, growth in pharma & biotech industries, and government initiatives to reduce HAIs and implement effective sterilization practices. Asia-Pacific emerges as a high-growth region with significant potential, propelled by expanding healthcare infrastructure, rising quality standards in manufacturing, government initiatives for healthcare modernization, and growing awareness of infection control measures across various industries. Europe represents a substantial market, supported by stringent regulatory frameworks, advanced healthcare systems, growing demand for specialized sterilization solutions, and presence of leading sterilization equipment manufacturers with emphasis on innovation and compliance. Request a customized research analysis tailored to your specific requirements: Dynamic Competitive Landscape Driving Innovation The global sterilization equipment market features an innovative competitive ecosystem comprising specialized sterilization equipment manufacturers, healthcare technology companies, and integrated solution providers. This diverse landscape fosters rapid technological advancement through cutting-edge automation integration and specialized sterilization expertise development. Industry leaders are implementing comprehensive solutions that combine advanced sterilization technologies with monitoring systems, validation services, and regulatory compliance capabilities. Companies are pursuing strategic partnerships and acquisitions while addressing scalability and environmental sustainability challenges across different industry segments. Latest Industry Developments Recent market developments include: Advanced Low-Temperature Sterilization: Launch of innovative low-temperature sterilizers designed for heat-sensitive surgical instruments with advanced cross-contamination barrier technology EU GMP Compliance Solutions: Introduction of specialized sterilization bags and covers supporting EU GMP Annex 1 compliance for biopharmaceutical companies Nitrogen Dioxide Innovation: Expansion of sterilization service portfolios through nitrogen dioxide gas technology offering enhanced microbial efficacy and environmental benefits Steam Monitoring Advancement: Development of comprehensive steam monitoring products including biological indicators, chemical indicators, and indicator tapes for enhanced sterile processing confidence Market Challenges and Revolutionary Solutions While the market shows strong growth potential, it faces challenges including adverse effects associated with ethylene oxide usage, safety concerns regarding instrument reprocessing, complex regulatory compliance requirements, and environmental sustainability pressures. However, significant opportunities exist through rising adoption of e-beam sterilization, growing demand in emerging markets, increasing utilization of CO2 sterilization technology, and enhanced focus on infection control across healthcare and non-healthcare sectors. The shift from reusable to disposable medical devices presents both challenges and opportunities, as manufacturers adapt their sterilization strategies while healthcare facilities balance cost-effectiveness with infection prevention requirements. Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More) - Market Leaders Shaping Industry Future Key players driving the global sterilization equipment market include STERIS plc (U.S.), 3M Company (U.S.), Getinge AB (Sweden), Cardinal Health, Inc. (U.S.), Advanced Sterilization Products, Inc. (U.S.) (A subsidiary of Fortive Corporation), Fedegari Autoclavi SpA (Italy), Stryker Corporation (U.S.), ANTONIO MATACHANA, S. A. (Spain), SteelcoBelimed AG (Switzerland), Sotera Health Company (U.S.), Benchmark Scientific Inc (U.S.), MMM Münchener Medizin Mechanik GmbH (Germany), Tuttnauer (Netherlands), Consolidated Sterilizer Systems (U.S.), and Andersen Sterilizers, Inc. (U.S.). These companies are focusing on strategies such as advanced automation technology integration, environmentally sustainable sterilization solution development, comprehensive service portfolio expansion, strategic partnerships and acquisitions, and geographic expansion into emerging markets to strengthen their market position. Related Reports: Medical Device Contract Manufacturing Market Pharmaceutical Contract Development and Manufacturing Market Pharmaceutical Processing Equipment Market Disinfection Robots Market Size, Share, Forecast, & Trends Microbial Control Chemical Market by Size, Share About Meticulous Research We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact:Mr. Khushal BombeMeticulous Market Research Pvt. Ltd.1267 Willis St, Ste 200 Redding,California, 96001, +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- sales@ Our Website: with us on LinkedIn- Source: Logo: View original content: SOURCE Meticulous Market Research Pvt. Ltd.

Philadelphia getting WNBA team as part of 3-team expansion by 2030: "The W's coming"
Philadelphia getting WNBA team as part of 3-team expansion by 2030: "The W's coming"

CBS News

time39 minutes ago

  • CBS News

Philadelphia getting WNBA team as part of 3-team expansion by 2030: "The W's coming"

The WNBA is finally coming to Philadelphia as part of a three-city expansion by 2030, Commissioner Cathy Engelbert and the 76ers announced Monday. The Philly team, owned by Harris Blitzer Sports & Entertainment, which also owns the Sixers, and Comcast Spectacor, will begin play in 2030. The announcement comes months after HBSE and Comcast announced a new shared arena with the Sixers and the Flyers set to open in 2031. "Philadelphia, the W's coming. Let's go, this is awesome," Harris said Monday. "To the city of Philly, this is your team. Philadelphia is a city about sports, and basketball in particular, including generations of extraordinary women's basketball talent, athletes who have shaped the game and inspired countless others." "For me and the community, bringing the WNBA to Philly wasn't just nice to have. It was an obligation." Harris said the WNBA team will give girls in the Philadelphia region a team to root for and be inspired by. "Sports have changed my life, and I've seen them change so many other lives," Harris said. "I have two daughters, one of whom is in the audience, and I believe deeply in the power of sports to inspire, uplift and teach. Lessons that carry far beyond athletics. Now, millions of girls will have the same opportunity." Engelbert, who is from Collingswood, New Jersey, cited the growing popularity of women's basketball and the WNBA beyond the latest expansion. The three new teams all have NBA ownership groups, and each paid a $250 million expansion fee. Engelbert, whose father, Kurt, played basketball at St. Joseph's University and is in the Big 5 Hall of Fame, also said the HBSE's long-term commitment to making a WNBA team work in Philadelphia was a key factor. "On behalf of the entire WNBA, I'm thrilled to welcome Cleveland and Detroit back and Philadelphia officially to the WNBA," Engelbert said. "These are proud cities with powerful sports legacies, each one rich in basketball tradition and fueled by passionate fan bases. We know they're going to show up for the W. Now, they join the most elite women's sports league in the world. It's far more than an expansion of our league. It's an evolution of it." Last year, while the Sixers were pushing to build a new arena in Center City, Philadelphia Mayor Cherelle Parker joined the call for the city to get a WNBA team. Parker said she believes the Sixers getting a new arena would help draw the league to Philadelphia. "We don't have a WNBA team here in the city of Philadelphia," Parker said in September 2024. "Do any of y'all ever notice that? Y'all know y'all mayor don't like that." In January, the Sixers' plans to build 76 Place at Market East were scrapped when the team and Comcast Spectacor announced plans for a new stadium in South Philadelphia. During the press conference announcing the shared arena in January, Emmy-winning comedian and actress Wanda Sykes also joined the fray to declare that now is the time to bring the WNBA to Philadelphia. This is a developing story and will be updated.

US to restart trade negotiations with Canada immediately, White House says
US to restart trade negotiations with Canada immediately, White House says

Yahoo

time39 minutes ago

  • Yahoo

US to restart trade negotiations with Canada immediately, White House says

WASHINGTON (Reuters) -The United States will restart trade negotiations with Canada immediately after Canada scrapped its digital services tax targeting U.S. technology firms, White House economic adviser Kevin Hassett said on Monday. "Absolutely," Hassett said on Fox News when asked about the talks restarting. President Donald Trump asked the Canadians to take the tax off at the G7 meeting in Canada, he said. "It's something that they've studied, now they've agreed to, and for sure, that means that we can get back to the negotiations." Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store